|
DE3922444A1
(de)
|
1988-03-01 |
1991-01-10 |
Deutsches Krebsforsch |
Virusmodifizierte tumorvakzine fuer die immuntherapie von tumormetastasen
|
|
DE3806565A1
(de)
|
1988-03-01 |
1989-09-14 |
Deutsches Krebsforsch |
Virusmodifizierte tumorvakzinen fuer die immuntherapie von tumormetastasen
|
|
US5223409A
(en)
|
1988-09-02 |
1993-06-29 |
Protein Engineering Corp. |
Directed evolution of novel binding proteins
|
|
US5166057A
(en)
|
1989-08-28 |
1992-11-24 |
The Mount Sinai School Of Medicine Of The City University Of New York |
Recombinant negative strand rna virus expression-systems
|
|
US5854037A
(en)
|
1989-08-28 |
1998-12-29 |
The Mount Sinai School Of Medicine Of The City University Of New York |
Recombinant negative strand RNA virus expression systems and vaccines
|
|
US5786199A
(en)
|
1989-08-28 |
1998-07-28 |
The Mount Sinai School Of Medicine Of The City University Of New York |
Recombinant negative strand RNA virus expression systems and vaccines
|
|
AU699487B2
(en)
|
1993-04-30 |
1998-12-03 |
Robert M. Lorence |
Methods of treating and detecting cancer using viruses
|
|
DK0702085T4
(da)
|
1994-07-18 |
2010-04-06 |
Conzelmann Karl Klaus Prof Dr |
Rekombinant infektiøs ikke-segmenteret negativ-strenget RNA-virus
|
|
US5891680A
(en)
|
1995-02-08 |
1999-04-06 |
Whitehead Institute For Biomedical Research |
Bioactive fusion proteins comprising the p35 and p40 subunits of IL-12
|
|
US7153510B1
(en)
|
1995-05-04 |
2006-12-26 |
Yale University |
Recombinant vesiculoviruses and their uses
|
|
ATE181112T1
(de)
|
1995-08-09 |
1999-06-15 |
Schweiz Serum & Impfinst |
Dem genom von minussträngigen rna-viren entsprechende cdna und verfahren zur herstellung von infektiösen minussträngigen rna-viren
|
|
JPH11512609A
(ja)
|
1995-09-27 |
1999-11-02 |
アメリカ合衆国 |
クローン化されたヌクレオチド配列からの感染性ＲＳウイルス（ｒｅｓｐｉｒａｔｏｒｙ ｓｙｎｃｙｔｉａｌ ｖｉｒｕｓ）の生産
|
|
CA2231603C
(en)
|
1995-10-17 |
2009-04-21 |
Wayne State University |
Chicken interleukin-15 and uses thereof
|
|
KR100894670B1
(ko)
|
1996-07-15 |
2009-04-22 |
더 가번먼트 오브 더 유나이티드 스테이츠 오브 아메리카, 에즈 레프리젠티드 바이 더 디파트먼트 오브 헬쓰 앤드 휴먼 서비시즈 |
클론닝된 뉴클레오타이드 서열로부터 약독화된 호흡기 세포융합 바이러스 백신의 생산
|
|
CN1232504A
(zh)
|
1996-09-27 |
1999-10-20 |
美国氰胺公司 |
在单链负义病毒目病毒内引起减毒的3'基因组启动子区和聚合酶基因中的突变
|
|
WO1998053078A1
(en)
|
1997-05-23 |
1998-11-26 |
The Government Of The United States Of America, As Represented By The Department Of Health And Humanservices |
Production of attenuated parainfluenza virus vaccines from cloned nucleotide sequences
|
|
ATE361973T1
(de)
|
1997-07-11 |
2007-06-15 |
Univ Yale |
Rhabdovirus mit gentechnisch veränderter hülle
|
|
KR20010030630A
(ko)
|
1997-09-19 |
2001-04-16 |
윌리암 에이취 캘넌, 에곤 이 버그 |
약독화 호흡 신시티아 바이러스
|
|
JP2001519175A
(ja)
|
1997-10-09 |
2001-10-23 |
プロ − バイラス，インコーポレイテッド |
ウイルスを用いた新生物の処置
|
|
US20030044384A1
(en)
|
1997-10-09 |
2003-03-06 |
Pro-Virus, Inc. |
Treatment of neoplasms with viruses
|
|
US7470426B1
(en)
|
1997-10-09 |
2008-12-30 |
Wellstat Biologics Corporation |
Treatment of neoplasms with viruses
|
|
US7780962B2
(en)
|
1997-10-09 |
2010-08-24 |
Wellstat Biologics Corporation |
Treatment of neoplasms with RNA viruses
|
|
PT1085904E
(pt)
|
1998-06-12 |
2013-03-05 |
Sinai School Medicine |
Vírus de cadeia negativa atenuados com actividade antagonista do interferão alterada, para utilização como vacinas e produtos farmacêuticos
|
|
EP0974660A1
(en)
|
1998-06-19 |
2000-01-26 |
Stichting Instituut voor Dierhouderij en Diergezondheid (ID-DLO) |
Newcastle disease virus infectious clones, vaccines and diagnostic assays
|
|
US6146642A
(en)
|
1998-09-14 |
2000-11-14 |
Mount Sinai School Of Medicine, Of The City University Of New York |
Recombinant new castle disease virus RNA expression systems and vaccines
|
|
US6544785B1
(en)
|
1998-09-14 |
2003-04-08 |
Mount Sinai School Of Medicine Of New York University |
Helper-free rescue of recombinant negative strand RNA viruses
|
|
US7052685B1
(en)
|
1998-10-15 |
2006-05-30 |
Trustees Of The University Of Pennsylvania |
Methods for treatment of cutaneous T-cell lymphoma
|
|
IL145899A0
(en)
|
1999-04-15 |
2002-07-25 |
Pro Virus Inc |
Treatment of neoplasms with viruses
|
|
US20030224017A1
(en)
|
2002-03-06 |
2003-12-04 |
Samal Siba K. |
Recombinant Newcastle disease viruses useful as vaccines or vaccine vectors
|
|
WO2000067786A1
(en)
|
1999-05-05 |
2000-11-16 |
University Of Maryland |
PRODUCTION OF NOVEL NEWCASTLE DISEASE VIRUS STRAINS FROM cDNAS AND IMPROVED LIVE ATTENUATED NEWCASTLE DISEASE VACCINES
|
|
DE122008000056I1
(de)
|
1999-07-14 |
2009-04-09 |
Sinai School Medicine |
In vitro-rekonstitution von segmentierten negativstrang-rna-viren
|
|
US6896881B1
(en)
|
1999-09-24 |
2005-05-24 |
Mayo Foundation For Medical Education And Research |
Therapeutic methods and compositions using viruses of the recombinant paramyxoviridae family
|
|
ATE451835T1
(de)
|
1999-09-24 |
2010-01-15 |
Mayo Foundation |
Therapeutische verfahren und zusammensetzungen unter verwendung von viren der rekombinanten familie der paramyxoviridae
|
|
AUPQ425699A0
(en)
*
|
1999-11-25 |
1999-12-23 |
University Of Newcastle Research Associates Limited, The |
A method of treating a malignancy in a subject and a pharmaceutical composition for use in same
|
|
WO2001052874A2
(en)
|
2000-01-20 |
2001-07-26 |
Universität Zürich Institut für Medizinische Virologie |
Intra-tumoral administration of il-12 encoding nucleic acid molecules
|
|
WO2001077394A1
(en)
|
2000-04-10 |
2001-10-18 |
Mount Sinai School Of Medicine Of New York University |
Screening methods for identifying viral proteins with interferon antagonizing functions and potential antiviral agents
|
|
US6818444B2
(en)
|
2000-08-04 |
2004-11-16 |
Heska Corporation |
Canine and feline proteins, nucleic acid molecules and uses thereof
|
|
FR2823222B1
(fr)
|
2001-04-06 |
2004-02-06 |
Merial Sas |
Vaccin contre le virus de la fievre du nil
|
|
US7740863B2
(en)
|
2001-04-06 |
2010-06-22 |
Merial |
Recombinant vaccine against West Nile Virus
|
|
WO2002102404A1
(en)
|
2001-06-18 |
2002-12-27 |
Institut National De La Recherche Agronomique |
Uses of cytokines
|
|
WO2003092579A2
(en)
|
2002-04-29 |
2003-11-13 |
Hadasit Medical Research Services And Development Company Ltd. |
Compositions and methods for treating cancer with an oncolytic viral agent
|
|
US20050191617A1
(en)
|
2002-06-03 |
2005-09-01 |
Makoto Inoue |
Pramyxovirusl vectors encoding antibody and utilization thereof
|
|
AU2003250575A1
(en)
|
2002-08-07 |
2004-02-25 |
Mmagix Technology Limited |
Apparatus, method and system for a synchronicity independent, resource delegating, power and instruction optimizing processor
|
|
SE0203159D0
(sv)
|
2002-10-25 |
2002-10-25 |
Electrolux Ab |
Handtag till ett motordrivet handhållet verktyg
|
|
AU2002953436A0
(en)
|
2002-12-18 |
2003-01-09 |
The University Of Newcastle Research Associates Limited |
A method of treating a malignancy in a subject via direct picornaviral-mediated oncolysis
|
|
US20040197312A1
(en)
|
2003-04-02 |
2004-10-07 |
Marina Moskalenko |
Cytokine-expressing cellular vaccine combinations
|
|
ATE516305T1
(de)
|
2004-02-27 |
2011-07-15 |
Inst Nat Sante Rech Med |
Il-15-bindungsstelle für il-15-ralpha und spezifische il-15-mutanten mit wirkung als agonisten/antagonisten
|
|
WO2005087931A1
(en)
|
2004-03-11 |
2005-09-22 |
Virotarg Pty Ltd |
Modified oncolytic viruses
|
|
CN101065144B
(zh)
*
|
2004-08-20 |
2012-06-13 |
溶瘤病毒有限公司 |
治疗血液癌症的方法和组合物
|
|
US8236298B2
(en)
*
|
2004-08-20 |
2012-08-07 |
Viralytics Limited |
Methods and compositions for treatment of hematologic cancers
|
|
NZ591733A
(en)
|
2004-11-12 |
2012-10-26 |
Bayer Schering Pharma Ag |
Recombinant newcastle disease virus comprising a transgene encoding a fusion protein comprising a binding domain and a heterologous domain comprising an enzyme
|
|
WO2006074526A1
(en)
|
2005-01-17 |
2006-07-20 |
Viralytics Limited |
Method and composition for treatment of neoplasms
|
|
WO2007001677A2
(en)
|
2005-05-17 |
2007-01-04 |
University Of Connecticut |
Compositions and methods for immunomodulation in an organism
|
|
WO2007008918A2
(en)
|
2005-07-08 |
2007-01-18 |
Wayne State University |
Virus vaccines comprising envelope-bound immunomodulatory proteins and methods of use thereof
|
|
EP1922085A4
(en)
*
|
2005-08-31 |
2009-12-30 |
Oncolytics Biotech Inc |
TREATMENT WITH ONCOLYTIC VIRUS AND IMMUNSTIMULANDS FOR INCREASED IN VIVO IMMUNE SYSTEM DETECTION OF NEOPLASMS
|
|
EP1777294A1
(en)
|
2005-10-20 |
2007-04-25 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
IL-15Ralpha sushi domain as a selective and potent enhancer of IL-15 action through IL-15Rbeta/gamma, and hyperagonist (IL15Ralpha sushi -IL15) fusion proteins
|
|
PT2529747T
(pt)
|
2005-12-02 |
2018-05-09 |
Icahn School Med Mount Sinai |
Vírus da doença de newcastle quiméricos que apresentam proteínas de superfície não nativas e suas utilizações
|
|
CN101374950B
(zh)
|
2006-01-13 |
2012-06-27 |
美国政府健康及人类服务部国立卫生研究院 |
用于在哺乳动物细胞中表达的密码子优化的IL-15和IL-15Rα基因
|
|
CA2647282A1
(en)
|
2006-04-05 |
2007-10-11 |
Pfizer Products Inc. |
Ctla4 antibody combination therapy
|
|
US20090175826A1
(en)
|
2006-06-05 |
2009-07-09 |
Elankumaran Subbiah |
Genetically-engineered newcastle disease virus as an oncolytic agent, and methods of using same
|
|
US20110044937A1
(en)
|
2006-07-27 |
2011-02-24 |
Ottawa Health Research Institute |
Staged immune-response modulation in oncolytic therapy
|
|
CA2723320C
(en)
|
2007-05-04 |
2019-06-11 |
University Health Network |
Il-12 immunotherapy for cancer
|
|
DK2388266T3
(da)
|
2007-05-11 |
2014-05-26 |
Altor Bioscience Corp |
Fusionsmolekyler og IL-15-varianter
|
|
US8354509B2
(en)
|
2007-06-18 |
2013-01-15 |
Msd Oss B.V. |
Antibodies to human programmed death receptor PD-1
|
|
NZ582330A
(en)
|
2007-06-27 |
2012-05-25 |
Marinepolymer Tech Inc |
COMPLEXES OF IL-15 AND IL-15Ra (RECEPTOR ALPHA) AND USES THEREOF
|
|
EP2085092A1
(en)
|
2008-01-29 |
2009-08-05 |
Bayer Schering Pharma Aktiengesellschaft |
Attenuated oncolytic paramyxoviruses encoding avian cytokines
|
|
EA201500417A1
(ru)
|
2008-08-25 |
2015-11-30 |
Эмплиммьюн, Инк. |
Композиции антагонистов pd-1 и способы применения
|
|
US8475790B2
(en)
|
2008-10-06 |
2013-07-02 |
Bristol-Myers Squibb Company |
Combination of CD137 antibody and CTLA-4 antibody for the treatment of proliferative diseases
|
|
CN101787373B
(zh)
|
2009-01-23 |
2013-06-19 |
中国人民解放军第二军医大学东方肝胆外科医院 |
一种携带外源基因在包装细胞中高效生产的重组病毒载体、其构建方法及其用途
|
|
ES2550179T3
(es)
|
2009-02-05 |
2015-11-05 |
Icahn School Of Medicine At Mount Sinai |
Virus quiméricos de la enfermedad de Newcastle y usos de los mismos
|
|
WO2010126766A1
(en)
|
2009-04-30 |
2010-11-04 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Inducible interleukin-12
|
|
US20100297072A1
(en)
*
|
2009-05-19 |
2010-11-25 |
Depinho Ronald A |
Combinations of Immunostimulatory Agents, Oncolytic Virus, and Additional Anticancer Therapy
|
|
WO2011020047A1
(en)
|
2009-08-14 |
2011-02-17 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Use of il-15 to increase thymic output and to treat lymphopenia
|
|
ES2622087T3
(es)
|
2009-08-21 |
2017-07-05 |
Merial, Inc. |
Vacuna recombinante contra paramyxovirus aviar y procedimiento de fabricación y utilización de la misma
|
|
AU2010303149B2
(en)
|
2009-09-30 |
2016-08-04 |
Board Of Regents, The University Of Texas System |
Combination immunotherapy for the treatment of cancer
|
|
US10238734B2
(en)
|
2010-03-23 |
2019-03-26 |
The Regents Of The University Of California |
Compositions and methods for self-adjuvanting vaccines against microbes and tumors
|
|
WO2012000188A1
(en)
|
2010-06-30 |
2012-01-05 |
Tot Shanghai Rd Center Co., Ltd. |
Recombinant tumor vaccine and method of producing such
|
|
DK3327040T3
(da)
|
2010-09-21 |
2021-09-20 |
Altor Bioscience Corp |
Multimeriske opløselige il-15-fusionsmolekyler og fremgangsmåder til at fremstille og anvende samme
|
|
CN104093830A
(zh)
|
2011-04-15 |
2014-10-08 |
吉恩勒克斯公司 |
减毒的痘苗病毒的克隆毒株及其使用方法
|
|
EP2537933A1
(en)
|
2011-06-24 |
2012-12-26 |
Institut National de la Santé et de la Recherche Médicale (INSERM) |
An IL-15 and IL-15Ralpha sushi domain based immunocytokines
|
|
WO2013053775A1
(en)
|
2011-10-11 |
2013-04-18 |
Universität Zürich Prorektorat Mnw |
Combination medicament comprising il-12 and an agent for blockade of t-cell inhibitory molecules for tumour therapy
|
|
EP2806883B1
(en)
*
|
2012-01-25 |
2019-04-24 |
DNAtrix, Inc. |
Biomarkers and combination therapies using oncolytic virus and immunomodulation
|
|
EP2669381A1
(en)
|
2012-05-30 |
2013-12-04 |
AmVac AG |
Method for expression of heterologous proteins using a recombinant negative-strand RNA virus vector comprising a mutated P protein
|
|
WO2014047350A1
(en)
|
2012-09-20 |
2014-03-27 |
Morningside Technology Ventures Ltd. |
Oncolytic virus encoding pd-1 binding agents and uses of the same
|
|
ES2747997T3
(es)
|
2012-10-24 |
2020-03-12 |
Novartis Ag |
Formas de IL-15R alfa, células que expresan formas de IL-15R alfa, y usos terapéuticos de IL-15R alfa y complejos IL-15/IL-15R alfa
|
|
NZ711946A
(en)
|
2013-03-14 |
2020-05-29 |
Icahn School Med Mount Sinai |
Newcastle disease viruses and uses thereof
|
|
US11401312B2
(en)
|
2013-04-19 |
2022-08-02 |
Cytune Pharma |
Cytokine derived treatment with reduced vascular leak syndrome
|
|
AU2014284100A1
(en)
|
2013-06-17 |
2015-12-24 |
Viralytics Limited |
Methods for the treatment of bladder cancer
|
|
CA2920539C
(en)
|
2013-08-08 |
2024-01-02 |
Cytune Pharma |
Combined pharmaceutical composition
|
|
KR102364523B1
(ko)
|
2013-08-08 |
2022-02-18 |
싸이튠 파마 |
Ｉｌ―１５ 및 ｉｌ―１５ｒ 알파 스시 도메인 기반 모듈로카인
|
|
PT3508209T
(pt)
|
2013-09-03 |
2022-05-27 |
Medimmune Ltd |
Composições que apresentam um vírus da doença de newcastle atenuado e métodos de utilização para o tratamento de neoplasias
|
|
WO2015127501A1
(en)
*
|
2014-02-27 |
2015-09-03 |
Viralytics Limited |
Combination method for treatment of cancer
|
|
EP2915569A1
(en)
|
2014-03-03 |
2015-09-09 |
Cytune Pharma |
IL-15/IL-15Ralpha based conjugates purification method
|
|
US10335460B2
(en)
|
2014-07-29 |
2019-07-02 |
Novartis Ag |
IL-15 and IL-15Rα heterodimer dose escalation regimens for treating conditions
|
|
WO2016048903A1
(en)
|
2014-09-22 |
2016-03-31 |
Intrexon Corporation |
Improved therapeutic control of heterodimeric and single chain forms of interleukin-12
|
|
BR112017012222A2
(pt)
|
2014-12-09 |
2018-01-30 |
Merck Sharp & Dohme |
métodos para derivar um biomarcador de assinatura gênica e para tratar um paciente que tem um tumor, método e sistema para testar uma amostra de tumor removida de um paciente, e, kit.
|
|
CN106166294A
(zh)
|
2015-05-18 |
2016-11-30 |
国科丹蓝生物科技（北京）有限公司 |
一种用于术前介入放疗治疗肿瘤的化合物
|
|
US10344067B2
(en)
|
2016-02-25 |
2019-07-09 |
Deutsches Krebsforschungszentrum |
RNA viruses expressing IL-12 for immunovirotherapy
|
|
CN105734023B
(zh)
|
2016-03-28 |
2019-04-26 |
江苏康缘瑞翱生物医药科技有限公司 |
一种重组新城疫病毒在制备抗肝癌药物中的应用
|